Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL)

Mise à jour : Il y a 4 ans
Référence : NCT00802737

Femme et Homme

  • | Pays :
  • Sweden
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of the trial is to investigate the efficacy and safety of ofatumumab retreatment and maintenance in patients with chronic lymphocytic leukemia who have previously responded or had disease stabilization after ofatumumab in an ongoing trial (Hx-CD20-406).


Critère d'inclusion

  • Leukaemia, Lymphocytic, Chronic

Liens